Novo Nordisk A/S (NVO)

Novo Nordisk A/S (NVO) is a healthcare company (drug manufacturers - general) based in Denmark. The share price is $40.61, down 2.38% on the day, which values the company at $178.98B. Price as of 17 Nov 2026, 17:35 UTC, from Yahoo Finance.

Key facts

Share price
$40.61−2.38% today
Market value
$178.98B
P/E ratio
10.3×last 12 months
Forward P/E
11.6×
Dividend yield
28.13%
Funk Score
81/100
200-week average
$80.5850% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Novo Nordisk A/S in more detail

NVO trades at 10.3× its last twelve months' earnings, 11.6× next year's expected earnings, 0.5× sales. It sits 50% below its 200-week average of $80.58.

Its Funk Score is 81 out of 100 (financial strength 6.6, profitability 7.7, growth 10.0, each out of 10).

In its favour: Share count keeps falling; High return on invested capital. Worth checking: Debt is growing faster than cash flow; Dividend is not covered by free cash flow.

8 of the superinvestors tracked here hold NVO, including Tom Gayner (0.8% of the portfolio), Lee Ainslie (0.7% of the portfolio), Sarah Ketterer (0.6% of the portfolio).

Superinvestors holding NVO

8 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:NVO vs ABT (Novo Nordisk A/S vs Abbott Laboratories)NVO vs PFE (Novo Nordisk A/S vs Pfizer)NVO vs DHR (Novo Nordisk A/S vs Danaher)NVO vs ISRG (Novo Nordisk A/S vs Intuitive Surgical)NVO vs GILD (Novo Nordisk A/S vs Gilead Sciences)

All health care companies by market valueLargest companies in DenmarkAll stocks A–Z

Novo Nordisk A/S (NVO): questions and answers

What is NVO's P/E ratio?

Novo Nordisk A/S trades at 10.3× its last twelve months' earnings and 11.6× next year's expected earnings.

What is NVO's PEG ratio?

Novo Nordisk A/S's PEG ratio is 4.31 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Novo Nordisk A/S's market cap?

Novo Nordisk A/S is valued at $178.98B at a share price of $40.61.

Is NVO above its 200-week moving average?

No. NVO is 49.6% below its 200-week average of $80.58. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Novo Nordisk A/S growing?

Over the last three fiscal years Novo Nordisk A/S's revenue grew 20.4% a year and its earnings per share 23.5% a year.

Does NVO pay a dividend?

Yes. Novo Nordisk A/S's dividend yield is 28.13%, or $1.80 a share a year, paying out 45% of earnings.

Cite this page

Funkfolio, “Novo Nordisk A/S (NVO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/NVO

Underlying data: Yahoo Finance; company filings with the SEC.